GlassScriptPhysician profile
David J Kadouri
NPI 1215376223
$3,982.28
in general payments reported to CMS, 2019-2025
21 companies · $57.76 in 2025
The $57.76 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,086 · 2021: $318 · 2022: $71.31 · 2023: $114 · 2024: $335 · 2025: $57.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $506.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,745.84 | 2019 | |
| Medtronic, INC. | $246.79 | 2021 | |
| Abbvie INC. | $245.15 | 2019-2024 | |
| Minerva Surgical, INC | $221.58 | 2023-2024 | |
| Hologic Sales and Service, LLC | $114.75 | 2021-2024 | Thinprep 2000 Processor, Aptima |
| Organon LLC | $95.46 | 2021-2025 | Nexplanon |
| Agile Therapeutics, INC. | $40.31 | 2021-2022 | |
| Daiichi Sankyo INC. | $31.50 | 2019 | |
| Radiometer America, INC | $28.62 | 2025 | |
| Avanos Medical | $24.94 | 2022 | |
| Shield Therapeutics INC | $24.77 | 2024 | |
| Astellas Pharma US INC | $24.25 | 2019 | |
| Exact Sciences Corporation | $20.16 | 2024 | Cologuard Collection Kit |
| Roche Diagnostics Corporation | $17.10 | 2019 | |
| Caldera Medical, INC | $16.16 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $15.82 | 2023 | |
| Axonics, INC. | $15.67 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.96 | 2019 | |
| Amgen INC. | $13.42 | 2019 | |
| Coopersurgical, INC. | $12.73 | 2023 | Paragard T 380a |
| Merck Sharp & Dohme LLC | $12.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kadouri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.